Scarica l'app Stockscreener
8.88
4.23%
0.36
Dopo l'orario di chiusura:
8.98
0.10
+1.13%
Precedente Chiudi:
$8.52
Aprire:
$8.69
Volume 24 ore:
34,274
Relative Volume:
0.20
Capitalizzazione di mercato:
$388.43M
Reddito:
-
Utile/perdita netta:
$-103.21M
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
$-26.70M
1 W Prestazione:
-1.33%
1M Prestazione:
+33.94%
6M Prestazione:
-42.75%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$8.536
$8.92
Intervallo di 1 settimana:
$8.50
$9.25
Portata 52W:
$4.42
$18.40
Engene Holdings Inc Stock (ENGN) Company Profile
Nome
Engene Holdings Inc
Settore
Industria
Telefono
(514) 332-4888
Indirizzo
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Engene Holdings Inc Borsa (ENGN) Ultime notizie
enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference - StockTitan
Forbion growth opportunities fund acquires $4.99m in Engene Holdings shares By Investing.com - Investing.com South Africa
Forbion growth opportunities fund acquires $4.99m in Engene Holdings shares - Investing.com Australia
FY2024 EPS Estimates for enGene Boosted by Leerink Partnrs - MarketBeat
EnGene Announces $60 Million Private Placement Financing - Marketscreener.com
enGene Holdings Inc. (NASDAQ:ENGN) Sees Significant Growth in Short Interest - MarketBeat
enGene secures $60 million in private placement By Investing.com - Investing.com Canada
enGene Announces $60 Million Private Placement Financing - citybiz
Why enGene Holdings Stock Is Trading Higher - Benzinga
enGene secures $60 million in private placement - Investing.com
EnGene Holdings Shares Rise After $60M Private Placement - MarketWatch
enGene Holdings Secures $60 Million for Genetic Medicines - TipRanks
EnGene Holdings Inc. announced that it expects to receive CAD 60.148968 million in funding from a group of investors - Marketscreener.com
EnGene Holdings Inc. announced that it expects to receive $60.148968 million in funding from a group of investors - Marketscreener.com
enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer - citybiz
enGene Holdings Announces Key Executive Appointments - TipRanks
EnGene Holdings Inc. Announces Executive Changes - Marketscreener.com
enGene CTO Anthony Cheung transitions to CSO, Joan Connolly to succeed - TipRanks
enGene Holdings Inc. (NASDAQ:ENGN) Major Shareholder Purchases $19,717.50 in Stock - MarketBeat
Forbion growth opportunities fund increases stake in Engene Holdings with $3 million purchase - Investing.com Australia
enGene Holdings Inc. (NASDAQ:ENGN) Receives $33.67 Average PT from Analysts - MarketBeat
Long Term Trading Analysis for (ENGN) - Stock Traders Daily
Short Interest in enGene Holdings Inc. (NASDAQ:ENGN) Rises By 130.0% - MarketBeat
(ENGN) Investment Report - Stock Traders Daily
Insider Buys Additional US$57k In enGene Holdings Stock - Yahoo Finance
This trade activity should not be overlooked: enGene Holdings Inc (ENGN) - SETE News
An Analysis of enGene Holdings Inc (ENGN)’s Potential Price Growth - Knox Daily
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - StockTitan
The Psychology of enGene Holdings Inc Inc. (ENGN) Price Performance: Understanding Market Sentiment - The InvestChronicle
enGene Holdings Inc. (NASDAQ:ENGN) CEO Ronald Harold Wilfred Cooper Buys 10,000 Shares - MarketBeat
engene CEO buys $57k in company shares - Investing.com
engene CEO buys $57k in company shares By Investing.com - Investing.com Canada
Perceptive Advisors LLC Trims Position in enGene Holdings Inc. (NASDAQ:ENGN) - MarketBeat
enGene Holdings Inc. (NASDAQ:ENGN) Sees Large Increase in Short Interest - MarketBeat
Engene shares hold as Oppenheimer stands by $30 target - Investing.com South Africa
Morgan Stanley maintains price target on Engene Holdings shares By Investing.com - Investing.com South Africa
Morgan Stanley maintains price target on Engene Holdings shares - Investing.com
EnGene Holdings Touches 52-Week Low After Drug Study Update - MarketWatch
The Future of enGene Holdings Inc: Analyzing ENGN - The InvestChronicle
enGene price target lowered to $17 from $26 at Leerink - TipRanks
SEC Form 424B3 filed by enGene Holdings Inc. - Quantisnow
enGene Holdings Excels in Bladder Cancer Treatment Trial - TipRanks
Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort - Business Wire
(ENGN) Technical Data - Stock Traders Daily
enGene Holdings Inc. (NASDAQ:ENGNW) Short Interest Up 7,700.0% in September - Defense World
Engene stock poised for upside as key bladder cancer trial results nearOppenheimer - Investing.com India
enGene (NASDAQ:ENGN) Receives Outperform Rating from Oppenheimer - MarketBeat
Engene Holdings Inc Azioni (ENGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Engene Holdings Inc Azioni (ENGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Forbion Growth Opportunities F | 10% Owner |
Sep 30 '24 |
Buy |
6.34 |
341,332 |
2,163,362 |
2,400,791 |
| Forbion Growth Opportunities F | 10% Owner |
Sep 27 '24 |
Buy |
5.97 |
41,639 |
248,699 |
2,059,459 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 01 '24 |
Buy |
6.44 |
35,279 |
227,158 |
2,436,070 |
| Forbion Growth Opportunities F | 10% Owner |
Dec 29 '23 |
Buy |
9.06 |
10,020 |
90,771 |
2,017,820 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 07 '24 |
Buy |
6.55 |
11,844 |
77,531 |
2,469,833 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 02 '24 |
Buy |
6.37 |
10,153 |
64,697 |
2,446,223 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 04 '24 |
Buy |
6.54 |
5,997 |
39,242 |
2,457,989 |
| Forbion Growth Opportunities F | 10% Owner |
Dec 28 '23 |
Buy |
7.69 |
5,050 |
38,827 |
2,007,800 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 03 '24 |
Buy |
6.48 |
5,769 |
37,397 |
2,451,992 |
| Forbion Growth Opportunities F | 10% Owner |
Dec 27 '23 |
Buy |
7.17 |
2,750 |
19,711 |
2,002,750 |
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):